|
|
|
|
LEADER |
01695nam a2200409 a 4500 |
001 |
1878502 |
005 |
20171111234700.0 |
008 |
030716s2002 nyua ob 001 0 eng d |
020 |
|
|
|a 0471461326
|q (electronic bk.)
|
020 |
|
|
|a 9780471461326
|q (electronic bk.)
|
020 |
|
|
|a 0471223808
|q (alk. paper)
|
020 |
|
|
|a 9780471223801
|q (alk. paper)
|
020 |
|
|
|a 0471224839
|q (electronic bk.)
|
020 |
|
|
|a 9780471224839
|q (electronic bk.)
|
020 |
|
|
|a 1280366745
|
020 |
|
|
|a 9781280366741
|
040 |
|
|
|a N$T
|b eng
|e pn
|
050 |
|
4 |
|a TP248.23
|b .D48 2002eb
|
100 |
1 |
|
|a Dhanda, Rahul K.
|
245 |
1 |
0 |
|a Guiding Icarus :
|b merging bioethics with corporate interests /
|c Rahul K. Dhanda ; foreword by Philip R. Reilly.
|
260 |
|
|
|a New York :
|b John Wiley & Sons,
|c ©2002.
|
300 |
|
|
|a 1 online resource (xxv, 270 pages) :
|b illustrations
|
504 |
|
|
|a Includes bibliographical references (pages 258-260) and index.
|
505 |
0 |
|
|a Introduction -- Genetically modified foods -- DNA data banking -- Personalized medicine -- Stem Cells -- Conclusion.
|
650 |
|
0 |
|a Biotechnology
|x Moral and ethical aspects.
|
650 |
|
0 |
|a Biotechnology industries.
|
650 |
|
2 |
|a Bioethical Issues.
|
650 |
|
2 |
|a Biotechnology.
|
650 |
|
4 |
|a Biotechnology
|x Moral and ethical aspects.
|
650 |
|
6 |
|a Bio-industries.
|
650 |
|
6 |
|a Biotechnologie
|x Aspect moral.
|
650 |
|
7 |
|a BUSINESS & ECONOMICS
|x Business Ethics.
|
650 |
|
7 |
|a Biotechnology industries.
|
650 |
|
7 |
|a Biotechnology
|x Moral and ethical aspects.
|
650 |
0 |
7 |
|a Bioethik.
|
856 |
4 |
0 |
|a Biotechnologie.
|u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=85507
|
952 |
|
|
|a CY-NiOUC
|b 5a04624f6c5ad14ac1ee7393
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|